Status:
COMPLETED
Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis
Lead Sponsor:
University of Aarhus
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
Severe atopic dermatitis (AD) is a recurrent and debilitating disease often requiring systemic immunosuppressive treatment. The efficacy of cyclosporine A (CsA) is well proven but potential side effec...
Eligibility Criteria
Inclusion
- Criteria of inclusion were refractoriness to standard topical treatment (corticosteroid ointments, UVA, UVB, PUVA, tar).
Exclusion
- Criteria of exclusion were pregnancy, uncontrolled hypertension, previous malignancy, infectious disease, liver/kidney disease or active treatment with ECP or immunosuppressants within 4 weeks prior to start of trial.
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2004
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02226068
Start Date
June 1 2002
End Date
January 1 2004
Last Update
March 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.